Side effects may include acute anterior uveitis and perforation of the globe. Keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids. LD50 = 234 mg/kg (rats)
A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Denosumab | The risk or severity of adverse effects can be increased when Denosumab is combined with Fluorometholone. |
| Etanercept | The risk or severity of adverse effects can be increased when Etanercept is combined with Fluorometholone. |
| Peginterferon alfa-2a | The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Fluorometholone. |
| Interferon alfa-n1 | The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Fluorometholone. |
| Interferon alfa-n3 | The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluorometholone. |
| Peginterferon alfa-2b | The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluorometholone. |
| Anakinra | The risk or severity of adverse effects can be increased when Anakinra is combined with Fluorometholone. |
| Interferon gamma-1b | The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluorometholone. |
| Interferon alfa-2a | The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Fluorometholone. |
| Aldesleukin | The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluorometholone. |
| Adalimumab | The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluorometholone. |
| Gemtuzumab ozogamicin | The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluorometholone. |
| Pegaspargase | The serum concentration of Fluorometholone can be increased when it is combined with Pegaspargase. |
| Infliximab | The risk or severity of adverse effects can be increased when Infliximab is combined with Fluorometholone. |
| Interferon beta-1b | The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Fluorometholone. |
| Interferon alfacon-1 | The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Fluorometholone. |
| Rituximab | The risk or severity of adverse effects can be increased when Rituximab is combined with Fluorometholone. |
| Basiliximab | The risk or severity of adverse effects can be increased when Basiliximab is combined with Fluorometholone. |
| Muromonab | The risk or severity of adverse effects can be increased when Muromonab is combined with Fluorometholone. |
| Ibritumomab tiuxetan | The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Fluorometholone. |
| Tositumomab | The risk or severity of adverse effects can be increased when Tositumomab is combined with Fluorometholone. |
| Alemtuzumab | The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Fluorometholone. |
| Alefacept | The risk or severity of adverse effects can be increased when Alefacept is combined with Fluorometholone. |
| Efalizumab | The risk or severity of adverse effects can be increased when Efalizumab is combined with Fluorometholone. |
| Antithymocyte immunoglobulin (rabbit) | The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Fluorometholone. |
| Interferon alfa-2b | The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Fluorometholone. |
| Daclizumab | The risk or severity of adverse effects can be increased when Daclizumab is combined with Fluorometholone. |
| Phenylalanine | The risk or severity of adverse effects can be increased when Phenylalanine is combined with Fluorometholone. |
| Flunisolide | The risk or severity of adverse effects can be increased when Flunisolide is combined with Fluorometholone. |
| Bortezomib | The risk or severity of adverse effects can be increased when Bortezomib is combined with Fluorometholone. |
| Cladribine | Fluorometholone may increase the immunosuppressive activities of Cladribine. |
| Carmustine | The risk or severity of adverse effects can be increased when Carmustine is combined with Fluorometholone. |
| Amsacrine | The risk or severity of adverse effects can be increased when Amsacrine is combined with Fluorometholone. |
| Bleomycin | The risk or severity of adverse effects can be increased when Bleomycin is combined with Fluorometholone. |
| Chlorambucil | The risk or severity of adverse effects can be increased when Chlorambucil is combined with Fluorometholone. |
| Raltitrexed | The risk or severity of adverse effects can be increased when Raltitrexed is combined with Fluorometholone. |
| Mitomycin | The risk or severity of adverse effects can be increased when Mitomycin is combined with Fluorometholone. |
| Bexarotene | The risk or severity of adverse effects can be increased when Bexarotene is combined with Fluorometholone. |
| Vindesine | The risk or severity of adverse effects can be increased when Vindesine is combined with Fluorometholone. |
| Floxuridine | The risk or severity of adverse effects can be increased when Floxuridine is combined with Fluorometholone. |
| Tioguanine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Tioguanine. |
| Vinorelbine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vinorelbine. |
| Dexrazoxane | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Dexrazoxane. |
| Beclomethasone dipropionate | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Beclomethasone dipropionate. |
| Sorafenib | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Sorafenib. |
| Streptozocin | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Streptozocin. |
| Trifluridine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Trifluridine. |
| Gemcitabine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Gemcitabine. |
| Betamethasone | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Betamethasone. |
| Teniposide | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Teniposide. |
| Epirubicin | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Epirubicin. |
| Chloramphenicol | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Chloramphenicol. |
| Lenalidomide | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Lenalidomide. |
| Altretamine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Altretamine. |
| Zidovudine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Zidovudine. |
| Oxaliplatin | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Oxaliplatin. |
| Cyclophosphamide | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Cyclophosphamide. |
| Vincristine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vincristine. |
| Fluorouracil | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fluorouracil. |
| Desoximetasone | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Desoximetasone. |
| Propylthiouracil | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Propylthiouracil. |
| Pentostatin | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Pentostatin. |
| Methotrexate | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Methotrexate. |
| Carbamazepine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Carbamazepine. |
| Vinblastine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Vinblastine. |
| Fluticasone propionate | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fluticasone propionate. |
| Fluocinolone acetonide | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fluocinolone acetonide. |
| Linezolid | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Linezolid. |
| Imatinib | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Imatinib. |
| Triamcinolone | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Triamcinolone. |
| Clofarabine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Clofarabine. |
| Prednisone | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Prednisone. |
| Pemetrexed | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Pemetrexed. |
| Fludrocortisone | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Fludrocortisone. |
| Mycophenolate mofetil | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Mycophenolate mofetil. |
| Daunorubicin | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Daunorubicin. |
| Irinotecan | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Irinotecan. |
| Methimazole | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Methimazole. |
| Mometasone | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Mometasone. |
| Etoposide | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Etoposide. |
| Dacarbazine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Dacarbazine. |
| Temozolomide | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Temozolomide. |
| Penicillamine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Penicillamine. |
| Prednisolone | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Prednisolone. |
| Sirolimus | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Sirolimus. |
| Azacitidine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Azacitidine. |
| Carboplatin | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Carboplatin. |
| Methylprednisolone | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Methylprednisolone. |
| Dactinomycin | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Dactinomycin. |
| Cytarabine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Cytarabine. |
| Azathioprine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Azathioprine. |
| Doxorubicin | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Doxorubicin. |
| Hydroxyurea | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Hydroxyurea. |
| Busulfan | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Busulfan. |
| Clobetasol propionate | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Clobetasol propionate. |
| Mycophenolic acid | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Mycophenolic acid. |
| Topotecan | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Topotecan. |
| Mercaptopurine | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Mercaptopurine. |
| Thalidomide | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Thalidomide. |
| Melphalan | The risk or severity of adverse effects can be increased when Fluorometholone is combined with Melphalan. |